Table 5.
Association between MIR31HG polymorphisms and ONFH risk stratified by necrotic sites.
| SNP | Model | Genotype | OR (95% CI) | p |
|---|---|---|---|---|
| rs10965059 | Allele | C | 1.00 | |
| T | 0.45 (0.32-0.65) | <0.001 | ||
| Codominant | CC | 1.00 | ||
| TT | 0.34 (0.07-1.60) | 0.171 | ||
| TC | 0.40 (0.27-0.59) | <0.001 | ||
| Dominant | CC | 1.00 | ||
| TT+TC | 0.39 (0.27-0.58) | <0.001 | ||
| Recessive | TC+CC | 1.00 | ||
| TT | 0.43 (0.09-2.03) | 0.284 | ||
| Additive | —– | 0.42 (0.29-0.61) | <0.001 |
SNP, Single nucleotide polymorphism; OR, Odd ratios; CI, Confidence interval.
p values were calculated from logistic regression.
Bold values indicate statistical significance (p < 0.05).